Cédric Révil
Impact in
Papers in
- Co-authors
- Michaela Lehle (1 shared paper)Bella Kaufman (1 shared paper)A. Feyereislova (2 shared papers)Sergei Tjulandin (1 shared paper)P. P. Bapsy (1 shared paper)Michaela K. Jahn (1 shared paper)Michael Clemens (1 shared paper)Alison Jones (1 shared paper)
- Journals
- Neuro-Oncology (6 papers)Journal of Clinical Oncology (5 papers)Annals of Oncology (3 papers)Neurology (1 paper)European Journal of Cancer (1 paper)
- Partner nations
- SwitzerlandUnited KingdomGermany
In The Last Decade
Cédric Révil
21 papers receiving 790 citations
Cédric Révil's Hit Papers
Peers
Comparison fields: 5 of 43
- Oncology 480
- Genetics 139
- Cancer Research 180
- Pulmonary and Respiratory Medicine 238
- Radiology, Nuclear Medicine and Imaging 155
Countries citing papers authored by Cédric Révil
This map shows the geographic impact of Cédric Révil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cédric Révil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cédric Révil more than expected).
Fields of papers citing papers by Cédric Révil
This network shows the impact of papers produced by Cédric Révil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cédric Révil. The network helps show where Cédric Révil may publish in the future.
Co-authors
The 25 scholars most cited alongside Cédric Révil, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Trastuzumab Plus Anastrozole Versus Anastrozole Alone for the Treatment of Postmenopausal Women With Human Epidermal Growth Factor Receptor 2–Positive, Hormone Receptor–Positive Metastatic Breast Cancer: Results From the Randomized Phase III TAnDEM Study Hit paper breakdown → | 2009 | 598 |
| 2 | 2016 | 68 | |
| 3 | 2016 | 32 | |
| 4 | 2017 | 23 | |
| 5 | 2019 | 22 | |
| 6 | 2012 | 16 | |
| 7 | 2014 | 14 | |
| 8 | 2020 | 8 | |
| 9 | 2017 | 5 | |
| 10 | 2014 | 5 | |
| 11 | 2016 | 3 | |
| 12 | 2015 | 3 | |
| 13 | 2009 | 2 | |
| 14 | 2016 | 2 | |
| 15 | 2014 | 2 | |
| 16 | 2016 | 2 | |
| 17 | 2019 | 2 | |
| 18 | 2014 | 1 | |
| 19 | 2025 | 1 | |
| 20 | 2014 | 1 |
About Cédric Révil
Cédric Révil is a scholar working on Genetics, Oncology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Molecular Biology, having authored 24 papers that have together received 811 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (11 papers), Cancer Treatment and Pharmacology (4 papers), Radiomics and Machine Learning in Medical Imaging (4 papers), HER2/EGFR in Cancer Research (3 papers), Colorectal Cancer Treatments and Studies (2 papers), Brain Metastases and Treatment (2 papers), Lung Cancer Treatments and Mutations (2 papers) and Gastric Cancer Management and Outcomes (2 papers). The work is most often cited by research in Oncology (480 citations), Genetics (139 citations), Cancer Research (180 citations), Pulmonary and Respiratory Medicine (238 citations) and Radiology, Nuclear Medicine and Imaging (155 citations). Cédric Révil has collaborated with scholars based in Switzerland, United Kingdom and Germany. Frequent co-authors include Michaela Lehle, Bella Kaufman, A. Feyereislova, Sergei Tjulandin, P. P. Bapsy, Michaela K. Jahn, Michael Clemens, Alison Jones, Andrew Wardley and John R. Mackey. Their work appears in journals such as Neuro-Oncology, Journal of Clinical Oncology, Annals of Oncology, Neurology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.